Potential therapy with the inhibitor of TGF-β receptors LY2109761 for oral squamous cell carcinoma. RSD [Internet]. 2021 Aug. 1 [cited 2025 Dec. 5];10(9):e54810918396. Available from: https://rsdjournal.org/rsd/article/view/18396